Fecal Microbiota Transplantation & Cholangitis

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.


Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.


Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: The Next Steps in This Promising Story.


Liver-Microbiome Axis in Health and Disease.


Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.


New Therapeutic Targets in Autoimmune Cholangiopathies.


Intestinal microbiota in primary sclerosing cholangitis.


Gut microbiome in primary sclerosing cholangitis: A review.


Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?


Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.


Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.


The Microbiome and Primary Sclerosing Cholangitis.


Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.


New Therapeutic Strategies for Primary Sclerosing Cholangitis.


Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.


Emerging pharmacologic therapies for primary sclerosing cholangitis.


Emerging treatments for primary sclerosing cholangitis.